FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

781492009: Dacomitinib (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3747351018 Dacomitinib en Synonym Active Entire term case insensitive SNOMED CT core module
3747352013 Dacomitinib (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dacomitinib Is a Quinazoline true Inferred relationship Existential restriction modifier
Dacomitinib Is a Piperidine true Inferred relationship Existential restriction modifier
Dacomitinib Is a Substance with protein-tyrosine kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Dacomitinib Has disposition Protein-tyrosine kinase inhibitor true Inferred relationship Existential restriction modifier
Dacomitinib Is a Substance with enzyme inhibitor mechanism of action false Inferred relationship Existential restriction modifier
Dacomitinib Is a Antineoplastic agent true Inferred relationship Existential restriction modifier
Dacomitinib Is a Substance with protein kinase inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dacomitinib Has active ingredient True Dacomitinib Inferred relationship Existential restriction modifier 1
Product containing dacomitinib (medicinal product) Has active ingredient True Dacomitinib Inferred relationship Existential restriction modifier 1
Product containing dacomitinib in oral dose form (medicinal product form) Has active ingredient True Dacomitinib Inferred relationship Existential restriction modifier 1
Product containing only dacomitinib in oral dose form (medicinal product form) Has active ingredient True Dacomitinib Inferred relationship Existential restriction modifier 1
Product containing precisely dacomitinib 15 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dacomitinib Inferred relationship Existential restriction modifier 1
Product containing precisely dacomitinib 15 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier 1
Dacomitinib monohydrate Is modification of True Dacomitinib Inferred relationship Existential restriction modifier
Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dacomitinib Inferred relationship Existential restriction modifier 1
Product containing precisely dacomitinib 30 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier 1
Product containing precisely dacomitinib 45 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dacomitinib Inferred relationship Existential restriction modifier 1
Product containing precisely dacomitinib 45 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier 1
Dacomitinib 45mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier
Vizimpro 45mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier
Vizimpro 15mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier
Dacomitinib 30mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier
Vizimpro 15mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) 30 tablet 3 x 10 tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier
Dacomitinib 45mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier
Dacomitinib 15mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier
Vizimpro 45mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier
Vizimpro 30mg tablets (Pfizer Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier
Dacomitinib 30mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance True Dacomitinib Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start